Asokan R | Tumor | Research Excellence Award

Published on by Oncology

Dr. Asokan R | Tumor | Research Excellence Award

Professor | Kongunadu College of Engineering and Technology | India 

Dr. Asokan R is a senior academic leader and researcher, currently serving as the Principal of Kongunadu College of Engineering and Technology, with more than three decades of experience in engineering education and administration. He holds a PhD from Anna University and has strong academic credentials from BITS Pilani, Pondicherry Engineering College, and Kongu Engineering College. His expertise includes telecommunications, image processing, wireless networks, network security, optimization techniques, and the Internet of Things. He has led and coordinated several funded research projects, faculty development programs, and international conferences. Dr. Asokan has an extensive publication record in areas such as deep learning, medical imaging, and network optimization. His contributions have been recognized with prestigious honors including the AICTE Lilavati Award, Best Principal Award, and multiple excellence awards. He is an active member of professional bodies like IEEE, CSI, IETE, and ISTE, contributing widely to academic councils and technical committees.

Citation Metrics (Scopus)

1231
900
600
300
0

Citations

1231

h-index

18

i10-index

30

Citations

h-index

i10-index

View ResearchGate Profile View Google Scholar Profile
 View Linkedin Profile

Featured Publications


A review of Quality of Service (QoS) routing protocols for mobile Ad hoc networks

– Proc. IEEE International Conference on Wireless Communication and Sensor Computing, 2010

Manuel Fernandez-Escabias | Cancer Science | Research Excellence Award

Published on by Oncology

Mr. Manuel Fernandez-Escabias | Cancer Science | Research Excellence Award

Predoctoral Researcher | University of Granada | Spain 

Mr. Manuel Fernández Escabias is a predoctoral researcher at the University of Granada with an outstanding academic record in Sport Sciences and a strong focus on exercise, physiology, and oncology. He is currently pursuing a PhD in biomedicine on multidisciplinary prehabilitation and rehabilitation to reduce postoperative complications in colon cancer surgery. Since joining the PROFITH research group in 2021, he has actively contributed to major national projects such as ONCOFIT and RESET, often serving as Project Manager. His work spans exercise oncology, virtual reality in rehabilitation, and lifestyle-based interventions for improving surgical outcomes. Despite his young age, he has authored multiple Q1 and D1 journal articles and has participated in over 30 national and international conferences. He has received several prestigious awards, including the Blas Cabrera Scholarship, Best Master’s Thesis Award, and University of Granada Talent Award. Alongside his research, he is also building a strong teaching profile in physiology and exercise science while mentoring undergraduate and postgraduate students.

 

Citation Metrics (Google Scholar)

49
40
30
20
10
0

Citations

49

h-index

3

i10-index

2

Citations

h-index

i10-index

View ResearchGate Profile View Google Scholar Profile

Featured Publications


Modulation of fatty acid metabolism via lactate-HCA1 signaling: potential therapeutic implications

– American Journal of Physiology: Cell Physiology, 2025 (1 citation)

Noha Elkady | Cancer Biomarkers | Research Excellence Award

Published on by Oncology

Prof. Noha Elkady | Cancer Biomarkers | Research Excellence Award 

Professor | Menofia University | Egypt

Professor Noha Mohamed Nour El-din El-Kady is a senior consultant of pathology at the Faculty of Medicine, Menoufiya University, Egypt, with an outstanding academic career spanning education, diagnostics, and research. She earned her MBBCH, MSc, and MD degrees with excellence from Menoufiya University and progressed through all academic ranks to full professorship. She has extensive teaching experience across medical and health disciplines, curriculum design, assessment, quality assurance, and postgraduate supervision. Dr. El-Kady is a highly experienced diagnostic pathologist skilled in histopathology, cytology, immunohistochemistry, and frozen sections. She has participated in more than 120 international workshops and serves as a peer reviewer for leading indexed journals, receiving an Outstanding Reviewer Award. Her research output includes over 25 publications focusing on cancer pathology, biomarkers, and tumor microenvironment. She has received multiple awards for academic excellence, research, teaching, and community service.

Citation Metrics (Google Scholar)

208
150
100
50
0

Citations

208

h-index

9

i10-index

9

Citations

h-index

i10-index

View ResearchGate Profile View Google Scholar Profile
 View LinkedIn Profile

Featured Publications


Immunohistochemical expression of cyclo-oxygenase-2 and liver X receptor-α in acne vulgaris


– Journal of Clinical and Diagnostic Research, 2017 (19 citations)

 

Hend Gamal | Cancer Biology | Young Scientist Award

Published on by Oncology

Dr. Hend Gamal | Cancer Biology | Young Scientist Award 

Academic Advisor | Fengkai Group | Egypt 

Dr. Hend Gamal is an Egyptian bio-nanotechnology researcher specializing in cancer biology, with a PhD focused on laser-activated gold nanoparticle–based photothermal therapy for breast cancer. She holds an MSc in cancer biology and a strong foundation in molecular biology, nanotechnology, animal models, and advanced imaging techniques. Her research integrates nanomedicine, photothermal/photodynamic therapies, AI, in silico methods, and CRISPR for innovative cancer treatments. Dr. Gamal has authored multiple high-impact publications in international journals and IEEE conferences, with additional contributions as a co-author and book chapter contributor. She actively serves as an academic advisor, instructor, mentor, reviewer, editorial board member, and guest editor across reputable scientific platforms. Her professional profile is strengthened by extensive workshops, certifications, and international conference presentations and invitations. Dr. Gamal has received prestigious research award nominations and continues to contribute globally to oncology, nanotechnology, and translational cancer research.

Citation Metrics (Google Scholar)

47
35
25
10
0

Citations

47

h-index

4

i10-index

2

Citations

h-index

i10-index

View ORCID Profile View Google Scholar Profile

Featured Publications


Beyond the Bacterial Microbiome: Exploring the Gut Virome and Mycobiome in Health and Disease

– Current Trends in Biomedical Engineering & Biosciences, 2025

 

Raheleh Farahzadi | Stem Cell Therapy | Women Researcher Award

Published on by Oncology

Assoc. Prof. Dr. Raheleh Farahzadi | Stem Cell Therapy | Women Researcher Award 

Tabriz University of Medical Sciences | Iran

 

Assoc. Prof. Dr. Raheleh Farahzadi is an accomplished biochemist with a PhD and over nine years of experience in higher education, research, and academic leadership in biochemistry, cell, and molecular biology. She is internationally recognized as a top 2% most influential scientist worldwide (Stanford–Elsevier, 2024 and 2025) with a strong research focus on stem cells, cancer biology, and regenerative medicine. She has led 16 university, national, and international research projects and published 69 peer-reviewed articles with an H-index of 35 and over 3,300 citations. An experienced educator, she has delivered diverse biomedical courses and mentored numerous undergraduate, master’s, and PhD students to successful academic outcomes. Her expertise spans advanced cellular, molecular, and stem cell techniques, grant writing, and scientific publishing. She serves as an editor for leading journals and as a reviewer for over 400 manuscripts in high-impact journals. Currently based in Australia, she actively contributes to teaching, research, and collaborative biomedical innovation.

Citation Metrics (Google Scholar)

3374
2500
1500
500
0

Citations

3374

h-index

35

i10-index

58

Citations

h-index

i10-index

View ORCID Profile View Google Scholar Profile
 View ResearchGate Profile

Featured Publications

 

Ezzatollah Fathi | Cancer Stem Cell | Best Academic Researcher Award

Published on by Oncology

Prof. Ezzatollah Fathi | Cancer Stem Cell | Best Academic Researcher Award 

 University of Tabriz | Iran 

Prof. Ezzatollah Fathi is a senior academic and biomedical scientist serving as Professor at the University of Tabriz and Academic Sessional Lecturer at Victoria University, Australia, with extensive experience in teaching, research, and academic leadership. He holds a PhD in Clinical Pathology from the University of Tehran and a Doctorate in Veterinary Medicine from Ferdowsi University of Mashhad, both completed with high academic distinction. His teaching expertise covers biochemistry, hematology, clinical pathology, and clinical sciences across undergraduate, postgraduate, and doctoral programs. His research primarily focuses on stem cell biology, regenerative medicine, and cellular and molecular mechanisms of disease. Dr. Fathi has published more than 50 peer-reviewed articles and has served as principal investigator for several national and international research grants. He has supervised numerous undergraduate and postgraduate students, leading to successful theses, publications, and conference presentations. His scholarly impact has been internationally recognized through repeated inclusion in the Stanford–Elsevier list of the world’s top 2% most influential scientists.

Citation Metrics (Scopus)

2054
1500
1000
500
0

Citations

2,054

Documents

79

h-index

34

Citations

Documents

h-index

View Scopus Profile View Google Scholar Profile
 View ORCID Profile

Featured Publications

Zhi Cao | Cancer Research | Best Research Article Award

Published on by Oncology

Dr. Zhi Cao | Cancer Research | Best Research Article Award 

PhD Candidate | Chinese PLA General Hospital | China

Dr. Zhi Cao is a PhD candidate at the Chinese People’s Liberation Army General Hospital whose research profile reflects strong scientific rigor, innovation, and clinical relevance in cancer immunotherapy and neuroscience. Her authorship in a high-impact Nature Communications article demonstrates leadership in advancing translational oncology, where she contributed to pioneering preclinical and phase I clinical evidence showing that inhibition of glycosphingolipid synthesis using eliglustat can enhance the efficacy of immune checkpoint inhibitors in advanced cancers, a finding with direct implications for overcoming tumor immune resistance. This work, published in a Q1 journal with a high impact factor, highlights her ability to bridge molecular mechanisms with early-phase clinical application. Complementing this, her comprehensive review in Frontiers in Immunology systematically elucidates the synthesis, biological functions, and therapeutic potential of glycosphingolipids, reinforcing her expertise in tumor immunometabolism and immune modulation while guiding future therapeutic strategies. Beyond oncology, her interdisciplinary strength is evident in her Q1 Brain Research publication, where she applied single-cell molecular analyses to identify target cells and signaling pathways involved in conditioned fear memory, demonstrating technical versatility and strong analytical skills across biomedical domains. Her stated research interests in CAR-T cell immunotherapy and tumor therapy mechanisms align closely with global priorities in precision medicine and next-generation cancer treatments. Collectively, her publication record, impact factor profile, methodological depth, and translational focus indicate a researcher with significant promise and originality, making her a strong and credible candidate for recognition associated with a Best Research Article or similar high-level academic distinction.

Profile: ORCID

Featured Publications

Dong, L., Cao, Z., Chen, M., et al. (2024). Inhibition of glycosphingolipid synthesis with eliglustat in combination with immune checkpoint inhibitors in advanced cancers: Preclinical evidence and phase I clinical trial. Nature Communications, 15.

Dong, L., Cao, Z., Han, W., & Wu, Z. (2025). Synthesis, function, and therapeutic potential of glycosphingolipids. Frontiers in Immunology, 16.

Shen, M., Cao, Z., Tian, R., et al. (2023). Single-cell molecular alterations reveal target cells and pathways of conditioned fear memory. Brain Research, 1798.

Dr. Zhi Cao’s research advances global cancer innovation by uncovering novel immunometabolic mechanisms that enhance the effectiveness of immunotherapies and CAR-T strategies. By bridging molecular discovery with early-phase clinical translation, her work accelerates precision oncology solutions with the potential to improve patient outcomes worldwide.